Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 8/20 | 0.59 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.59 |
| ▸ | TACR3 | P29371 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7684854 | 1.00 | TACR1 (0.59) | TACR1HSD11B1TACR3CHRM1OPRM1 | |
| SCHEMBL7686628 | 0.88 | CHRM1 (0.60) | TACR1HSD11B1CHRM1OPRM1OPRK1 | |
| SCHEMBL7686622 | 0.88 | CHRM1 (0.60) | TACR1HSD11B1CHRM1OPRM1OPRK1 | |
| SCHEMBL7682877 | 0.84 | OPRM1 (0.57) | CHRM1OPRM1OPRK1OPRL1CHRM2 | |
| SCHEMBL1401249 | 0.83 | TACR1 (0.69) | TACR1TACR3 | |
| SCHEMBL1400972 | 0.83 | TACR1 (0.69) | TACR1TACR3 | |
| SCHEMBL733636 | 0.83 | TACR1 (0.69) | TACR1TACR3 | |
| SCHEMBL1400971 | 0.83 | TACR1 (0.69) | TACR1TACR3 | |
| SCHEMBL4819222 | 0.82 | TACR1 (0.68) | TACR1TACR3 | |
| SCHEMBL4819217 | 0.82 | TACR1 (0.68) | TACR1TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6346540-B1 | SUBSTANCE P ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM, PSYCHOLOGICAL AND BRAIN DISORDERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-02-12 | — | — | US | disclosed |
| EP-0855999-B1 | 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2001-10-04 | — | — | EP | disclosed |
| US-6169097-B1 | 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-02 | — | — | US | disclosed |
| EP-0855999-A1 | 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-08-05 | — | — | EP | disclosed |
| WO-1997024324-A1 | 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-07-10 | — | — | WO | disclosed |